JAMA Oncology

BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients – A Review

Importance  Half of all carriers of inherited cancer-predisposing variants in BRCA1 and BRCA2 are male, but the implications for their health are underrecognized compared to female individuals. Germline variants in BRCA1 and BRCA2 (also known as pathogenic or likely pathogenic variants, referred to here as BRCA1/2 PVs) are well known to…

Contemporary Management of Acute Myeloid Leukemia – A Review

Importance  Acute myeloid leukemia (AML) is a clonal hematopoietic cancer that disrupts normal hematopoiesis, ultimately leading to bone marrow failure and death. The annual incidence rate of AML is 4.1 per 100 000 people in the US and is higher in…

An Anal Lesion in a 27-Year-Old Patient

A 27-year-old male patient presented with anal discomfort and pruritus for 3 months. What is your diagnosis?

Recurrent Fevers in a Patient With Splenomegaly

A 36-year-old man presented with 10 weeks of recurrent fevers, malaise, night sweats, unintentional weight loss, and dyspnea. What is your diagnosis?

Lymphoma With a Skin Rash

A 62-year-old female had a generalized vesiculobullous rash on her face for 4 months. It started over the lips and gradually progressed to involve the oral mucosa and skin of the whole body. What is your diagnosis?  

Current Management of Desmoid Tumors – A Review

Importance  Desmoid tumor (DT) is a rare and locally aggressive monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Previously, surgery was the standard primary treatment modality; however, within the past decade, a paradigm shift toward less-invasive management…

Obstacles to Biosimilar Acceptance and Uptake in Oncology – A Review

Importance  Biosimilar drugs provide cost-effective yet clinically indistinguishable replications of target drugs. During initial development, this class of biologic medicines was expected to revolutionize pharmaceutical markets; however, following US Food and Drug Administration approval of the first biosimilar drug in 2015,…